Summerset Group Holdings Limited (ASX:SNZ)
Australia · Delayed Price · Currency is AUD 9.97
0.00 (0.00%)
Aug 14, 2025, 1:27 PM AEST
Summerset Group Holdings Revenue
In the year 2024, Summerset Group Holdings had annual revenue of 318.61M NZD with 17.79% growth. Summerset Group Holdings had revenue of 167.56M in the half year ending December 31, 2024, with 34.95% growth.
Revenue
318.61M NZD
Revenue Growth
+17.79%
P/S Ratio
8.23
Revenue / Employee
103.92K NZD
Employees
3,066
Market Cap
2.37B AUD
Revenue Chart
* This company reports financials in NZD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 318.61M | 48.11M | 17.79% |
| Dec 31, 2023 | 270.50M | 32.20M | 13.51% |
| Dec 31, 2022 | 238.30M | 33.01M | 16.08% |
| Dec 31, 2021 | 205.29M | 32.92M | 19.10% |
| Dec 31, 2020 | 172.37M | 18.64M | 12.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Ramsay Health Care | 17.12B |
| Telix Pharmaceuticals | 783.21M |
| Ansell | 3.00B |
| Mesoblast | 9.16M |
Summerset Group Holdings News
- 7 months ago - Summerset Group’s mistake and why $450m project is mainly unsold - NZ Herald